Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal

Overview of attention for article published in PharmacoEconomics, November 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Readers on

mendeley: 3 Mendeley

Summary X Facebook

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,175 followers.

Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal. #lymphoma #lymsm https://t.co/4mSos5WFln

23 Nov 2018

Reply Repost Favourite

#HealthEconJA Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal https://t.co/7slgx0xVq8

22 Nov 2018

Reply Repost Favourite